Cas:17455-25-3 dibenzo-30-crown-10 manufacturer & supplier

Chemical Name:dibenzo-30-crown-10

CAS.NO:17455-25-3

Synonyms:6,7,9,10,12,13,15,16,23,24,26,27,29,30,32,33-Hexadecahydrodibenzo[b,q][1,4,7,10,13,16,19,22,25,28]decaoxacyclotriacontine;Dibenzo(b,q)(1,4,7,10,13,16,19,22,25,28)decaoxacyclotriacontin, 6,7,9,10,12,13,15,16,23,24,26,27,29,30,32,33-hexadecahydro-;Dibenzo-30-crown 10-Ether;Dibenzo[b,q][1,4,7,10,13,16,19,22,25,28]decaoxacyclotriacontin, 6,7,9,10,12,13,15,16,23,24,26,27,29,30,32,33-hexadecahydro-;Dibenzo-30-crown-10;MFCD00054624

Molecular Formula:C₂₈H₄₀O₁₀

Molecular Weight:536.611

HS Code:2932999099

Physical and Chemical Properties:

Melting point:106-108 °C(lit.)

Boiling point:671.0±55.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.466

PSA:92.30000

Exact Mass:536.262146

LogP:1.29

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6,7,9,10,12,13,15,16,23,24,26,27,29,30,32,33-Hexadecahydrodibenzo[b,q][1,4,7,10,13,16,19,22,25,28]decaoxacyclotriacontine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00054624 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dibenzo-30-crown-10 Use and application,Dibenzo-30-crown-10 technical grade,usp/ep/jp grade.

Related News: The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured. dibenzo-30-crown-10 manufacturer Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. dibenzo-30-crown-10 supplier Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. dibenzo-30-crown-10 vendor In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. dibenzo-30-crown-10 factory In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company.